glp-1 colorectal cancer death risk study november 2025 Glucagon-like peptide 1 receptor agonists and risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research GLP-1 receptor agonists show anti-cancer

2026;3:101465 DOI: Received: January 25, 2026 Accepted: March 26, 2026 Published: April 02, 2026 Academic Editor: Marijn Speeckaert, Universitair Ziekenhuis Ghent, Belgium Epiploic appendagitis is a rare, self-limiting inflammatory condition of the colonic epiploic appendages

That gets back to the preclinical and clinical obesity

Kidney International Supplements 2016;6(1):20e8

NP levels serve as a biochemical marker of cardiorenal impairment providing additional information beyond imaging in the evaluation of HFimpEF

France, N

The third product is Berberine Advanced, which Zabihi said is positioned as an alternative to GLP-1 drugs as it doesnt come with the extreme side effects of Ozempic or Wegovy